HR 586 119th Congress House Armed Forces and National Security Asia Cancer Conflicts and wars Congressional oversight Government studies and investigations Health information and medical records Medical research Veterans' medical care Vietnam

Vietnam Veterans Liver Fluke Cancer Study Act

Introduced: January 21, 2025 Introduced by: LaLota, Nick Republican · New York See on congress.gov

Everywhere this bill has been 12 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 8, 2025

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Apr 7, 2025

Motion to reconsider laid on the table Agreed to without objection.

Apr 7, 2025

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)

Apr 7, 2025

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)

Apr 7, 2025

Considered as unfinished business. (consideration: CR H1441-1442)

Apr 7, 2025

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Apr 7, 2025

DEBATE - The House proceeded with forty minutes of debate on H.R. 586.

Apr 7, 2025

Considered under suspension of the rules. (consideration: CR H1435-1437)

Apr 7, 2025

Mr. Bost moved to suspend the rules and pass the bill, as amended.

Feb 25, 2025

Referred to the Subcommittee on Health.

Jan 21, 2025

Referred to the House Committee on Veterans' Affairs.

Jan 21, 2025

Introduced in House

Votes taken on this bill 1

Date	Chamber	What was voted on	Result	Yes–No
Apr 7, 2025	House · vote #89	On Motion to Suspend the Rules and Pass, as Amended	Passed	411–0	See who voted →

Plain-English summary Congressional Research Service

Vietnam Veterans Liver Fluke Cancer Study Act

This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.

The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

What's happening now April 8, 2025

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Committees of jurisdiction 3